Source:http://linkedlifedata.com/resource/pubmed/id/19412580
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2009-10-23
|
pubmed:abstractText |
In our previous study, chitosan-alginate microcapsules were developed to protect egg yolk immunoglobulin (IgY) from gastric inactivation. The present study was undertaken to determine the effect of chitosan concentration (0-0.8%; w/v) on various properties of the microcapsules in order to produce the optimum chitosan-alginate microcapsules for use in the oral delivery of IgY. The properties investigated included microcapsule morphology, loading capacity for IgY (expressed as the IgY loading percentage, w/w, of microcapsules), encapsulation efficiency (EE%), in vitro gastroresistance, and IgY release. IgY loading percentage and EE% were both highest at 0.2% (w/v) chitosan, and, above this level, further increases were not observed. The stability of IgY in simulated gastric fluid (pH 1.2) was significantly improved by encapsulation in alginate microcapsules (IgY retained 43.5% of its activity) and was further improved by including chitosan at any of the chitosan concentrations assessed (IgY retained an average of 69.4% activity) although there was no difference in protection of gastric inactivation among concentrations of chitosan varying from 0.05% to 0.8% (w/v). Higher chitosan concentrations (i.e., >/=0.2%; w/v) prolonged the release of IgY from the microcapsules during simulated intestinal fluid incubation (pH 6.8). However, above the 0.2% (w/v) level, no significant differences were observed. We conclude that the optimum chitosan concentration for microencapsulation is 0.2% (w/v).
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Alginates,
http://linkedlifedata.com/resource/pubmed/chemical/Capsules,
http://linkedlifedata.com/resource/pubmed/chemical/Chitosan,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Carriers,
http://linkedlifedata.com/resource/pubmed/chemical/Glucuronic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Hexuronic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/IgY,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulins,
http://linkedlifedata.com/resource/pubmed/chemical/alginic acid
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1559-0291
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
159
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
778-87
|
pubmed:meshHeading |
pubmed-meshheading:19412580-Administration, Oral,
pubmed-meshheading:19412580-Alginates,
pubmed-meshheading:19412580-Animals,
pubmed-meshheading:19412580-Capsules,
pubmed-meshheading:19412580-Chitosan,
pubmed-meshheading:19412580-Drug Carriers,
pubmed-meshheading:19412580-Egg Yolk,
pubmed-meshheading:19412580-Glucuronic Acid,
pubmed-meshheading:19412580-Hexuronic Acids,
pubmed-meshheading:19412580-Immunoglobulins,
pubmed-meshheading:19412580-Microscopy, Electron, Scanning
|
pubmed:year |
2009
|
pubmed:articleTitle |
Chitosan-alginate microcapsules for oral delivery of egg yolk immunoglobulin (IgY): effects of chitosan concentration.
|
pubmed:affiliation |
Department of Bioscience and Biotechnology, Dalian University of Technology, No. 2 Linggong Road, Dalian, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|